About this trial
We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model.
Eligibility criteria
Qualifiers
18 years of age or older.
Adequate venous access.
Have a blood pressure less than or equal to 180/100: pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer.
Have adequate blood counts (volunteers living with HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000; volunteers living without HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000
Disqualifiers
Pregnant and/or breastfeeding females.
Active substance abuse or history of prior substance abuse that may interfere with protocol compliance or compromise volunteer safety.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Lead sponsor
Medstar Health Research Institute
Collaborator